高级检索
当前位置: 首页 > 详情页

Human chorionic gonadotropin promotes cell proliferation through the activation of c-Met in gastric cancer cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Endoscopy Center, Sichuan Cancer Hospital, Chengdu, Sichuan 610041 [2]Medical Research Center, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China [3]Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China
出处:
ISSN:

关键词: human chorionic gonadotropin gastric cancer proliferation hepatocyte growth factor transmembrane protein receptor

摘要:
Hormones and their receptors affect the development process of gastric cancer. Previous studies have revealed that human chorionic gonadotropin (hCG) is expressed in gastric cancer tissue. However, the mechanism by which hCG exerts its effects on gastric cancer cells had not been reported. In the present study, the expression of hCG and its receptor was detected in gastric cancer tissues and para-carcinoma tissues of 62 patients with gastric carcinoma. Following the treatment of gastric cancer cells SGC-7901 with hCG, a cell counting kit-8 assay, flow cytometry, a colony formation assay and a xenograft tumor model in nude mice were used to detect the effect of hCG on cell proliferation; and the expression of c-Met was determined by western blot analysis. The expression of hCG and its receptor were significantly higher in gastric cancer tissues compared with that of the matched para-carcinoma tissue (P<0.01). Proliferation of SGC-7901 cells treated with hCG was significant higher and the number of cells at the G(2)/M phase of the cell cycle increased compared with the control cells. Hepatocyte growth factor transmembrane protein receptor expression was increased in hCG-treated cells compared with the control cells, which relies on the protein kinase A signaling pathway. The present study revealed the potential function of hCG in the development of gastric cancer, suggesting that hCG may be a molecular marker and potential drug target in gastric cancer.

基金:

基金编号: 81502075 2014JY0136 2014JY0017 2015FZ0072 2015-HM01-00141-SF 2015-HM01-00143-SF 2015-HM01-00139-SF

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q4 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Endoscopy Center, Sichuan Cancer Hospital, Chengdu, Sichuan 610041
共同第一作者:
通讯作者:
通讯机构: [1]Department of Endoscopy Center, Sichuan Cancer Hospital, Chengdu, Sichuan 610041 [3]Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu, Sichuan 610031, P.R. China [*1]Department of Endoscopy Center, Sichuan Cancer Hospital, 55 South Renmin Road, Chengdu, Sichuan 610041, P.R. China [*2]Department of Gastroenterology, The Third People's Hospital of Chengdu, 82 Quinglong Street, Chengdu, Sichuan 610031, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号